| Date | Time | Source | Headline | Symbol | Company |
| 10/06/2008 | 7:20PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/06/2008 | 7:20PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/06/2008 | 7:19PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/06/2008 | 7:19PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/06/2008 | 7:19PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/06/2008 | 7:19PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/06/2008 | 7:18PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/06/2008 | 7:18PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/01/2008 | 4:05PM | PR Newswire (US) | Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Soci | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/30/2008 | 2:11PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Confidential Treatment Order (CT ORDER) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/12/2008 | 4:28PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/09/2008 | 7:30AM | PR Newswire (US) | First Reported Head-to-Head Study Showed BYETTA(R) (exenatide) Injection Provided Greater Reduction in Post-Meal Glucose Levels | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/29/2008 | 4:32PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Beneficial Ownership (SC 13D) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/29/2008 | 4:30PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/29/2008 | 4:29PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/29/2008 | 10:50AM | PR Newswire (US) | BeaconEquity.com Issues Technical Trade Alerts on BioPharmaceutical Stocks: CEGE, AMLN, DNA, GENZ, AMGN, GILD | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/28/2008 | 4:05PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at Thomas Weisel Healthcare, BioCentury NewsMakers, and Morgan Stanley Global Healthcare Confe | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/28/2008 | 11:11AM | Marketwired | BellwetherReport.com Analyst Opinions on SEED, AMLN, ENER and CPST | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/27/2008 | 10:18AM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Confidential Treatment Order (CT ORDER) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/26/2008 | 5:46PM | PR Newswire (US) | Amylin Pharmaceuticals and Eli Lilly Provide Context for FDA Alert for BYETTA | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/25/2008 | 5:00PM | PR Newswire (US) | Lilly and Amylin Set Date and Time for Conference Call | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/25/2008 | 5:00PM | PR Newswire (US) | Amylin and Lilly Set Date and Time for Conference Call | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/20/2008 | 12:55PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/08/2008 | 7:30PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/31/2008 | 4:16PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Quarterly Report (10-Q) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/22/2008 | 11:46AM | Marketwired | BellwetherReport.com Analyst Report on BRCD, AMLN, WGOV and PCAR | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/21/2008 | 4:15PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/21/2008 | 4:05PM | PR Newswire (US) | Amylin Pharmaceuticals Reports Second Quarter Financial Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/15/2008 | 4:05PM | PR Newswire (US) | Amylin Pharmaceuticals to Webcast Second Quarter Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/11/2008 | 12:33PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Prospectus filed pursuant to Rule 424(b)(3) (424B3) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |